These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21897618)

  • 1. A review on recent advances in dry eye: Pathogenesis and management.
    Bhavsar AS; Bhavsar SG; Jain SM
    Oman J Ophthalmol; 2011 May; 4(2):50-6. PubMed ID: 21897618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic dry eye: focus on cyclosporine.
    Kymionis GD; Bouzoukis DI; Diakonis VF; Siganos C
    Clin Ophthalmol; 2008 Dec; 2(4):829-36. PubMed ID: 19668437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on dry eye disease molecular treatment: advances in drug pipelines.
    Colligris B; Crooke A; Huete-Toral F; Pintor J
    Expert Opin Pharmacother; 2014 Jul; 15(10):1371-90. PubMed ID: 24773445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of Langerhans Cells in the Central Cornea as Tool for Monitoring Inflammatory Changes in Patients with Keratoconjunctivitis sicca under Topical Therapy with Cyclosporine A 0.05% Eye Drops].
    Schneider E; Paulsen F; Jacobi C
    Klin Monbl Augenheilkd; 2020 May; 237(5):669-674. PubMed ID: 32434251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.
    Pron G; Ieraci L; Kaulback K;
    Ont Health Technol Assess Ser; 2011; 11(5):1-89. PubMed ID: 23074417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eye in Parkinson's disease: a narrative review.
    Ungureanu L; Chaudhuri KR; Diaconu S; Falup-Pecurariu C
    Front Neurol; 2023; 14():1236366. PubMed ID: 37602267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and management of dry eye: a twenty-five-year review.
    Pflugfelder SC; Solomon A; Stern ME
    Cornea; 2000 Sep; 19(5):644-9. PubMed ID: 11009316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.
    Gumus K; Cavanagh DH
    Clin Ophthalmol; 2009; 3():57-67. PubMed ID: 19668545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in dry eye: etiology, pathogenesis and management].
    Qin Y; Pan ZQ
    Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):857-63. PubMed ID: 24330938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical and herbal products that may contribute to dry eyes.
    Askeroglu U; Alleyne B; Guyuron B
    Plast Reconstr Surg; 2013 Jan; 131(1):159-167. PubMed ID: 23271525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punctal occlusion for dry eye syndrome.
    Ervin AM; Law A; Pucker AD
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithmic approach to diagnosis and management of post-refractive surgery dry eye disease.
    D'Souza S; James E; Swarup R; Mahuvakar S; Pradhan A; Gupta K
    Indian J Ophthalmol; 2020 Dec; 68(12):2888-2894. PubMed ID: 33229664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
    Downie LE; Ng SM; Lindsley KB; Akpek EK
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eye diagnosis and management in 2004.
    Perry HD; Donnenfeld ED
    Curr Opin Ophthalmol; 2004 Aug; 15(4):299-304. PubMed ID: 15232468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutical approach to dry eye syndrome].
    Babić GS; Zlatanović G; Jocić JD; Cekić S; Vujanović M
    Med Pregl; 2010; 63(11-12):793-800. PubMed ID: 21553457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triple classification of dry eye for practical clinical use.
    Murube Spain J; Nemeth Hungary J; Hoh Germany H; Kaynak-Hekimhan Turkey P; Horwarth-Winthers J; Agarwal India A; Baudouin France C; Benitez Del Castillo JM; Cervenka Czech Republic S; ChenZhuo China L; Ducasse France A; Duran Spain J; Holly Usa F; Javate Philippines R; Nepp Austria J; Paulsen Germany F; Rahimi Iran A; Raus Belgium P; Shalaby Egypt O; Sieg Germany P; Soriano Argentina H; Spinelli Italy D; Ugurbas Turkey SH; van Setten Sweden G
    Eur J Ophthalmol; 2005; 15(6):660-667. PubMed ID: 28221432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.